# Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma

> clinical trial · VERIFIED · 2026-07-17

Status: NOT_YET_RECRUITING · Sponsor: Olivia Newton-John Cancer Research Institute · Condition: Recurrent Glioblastoma IDH Wildtype

- Company: Olivia Newton-John Cancer Research Institute
- Sector: Recurrent Glioblastoma IDH Wildtype
- Primary source: https://clinicaltrials.gov/study/NCT07712770

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.